The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
dc.contributor.author | Yildiz, Ramazan | |
dc.contributor.author | Buyukberber, Suleyman | |
dc.contributor.author | Koca, Dogan | |
dc.contributor.author | Korai, Lokman | |
dc.contributor.author | Ciltas, Aydin | |
dc.contributor.author | Unal, Olcun Umit | |
dc.contributor.author | Gumus, Mahmut | |
dc.date.accessioned | 2024-02-23T14:45:12Z | |
dc.date.available | 2024-02-23T14:45:12Z | |
dc.date.issued | 2013 | |
dc.department | NEÜ | en_US |
dc.description | 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/17307 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000335419603655 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience. | en_US |
dc.type | Conference Object | en_US |